PMGC Holdings ELAB
NASDAQ ELAB
$6.66 +0.56 (+9.18%)
At close: Aug 21, 2026 · 4:00 PM EDT

PMGC Holdings (ELAB) Cash from Investing Activities (2022 - 2026)

PMGC Holdings (ELAB) posted Cash from Investing Activities of -$2.5 million for Q1 2026, down 352.68% sequentially from -$548642.0 in Q4 2025, and down 1053.46% YoY from $260485.0 in Q1 2025.

PMGC Holdings (ELAB) Cash from Investing Activities (2022 - 2026) Analysis & Trends

PMGC Holdings has reported Cash from Investing Activities for 5 years, with the latest figure at -$2.5 million in Q1 2026.

  • Quarterly Cash from Investing Activities fell 1053.46% year-over-year to -$2.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$5.0 million (down 556.49% YoY) and the FY2025 annual result came in at -$2.8 million, down 352.89% from the prior year.
  • Cash from Investing Activities slipped to -$2.5 million in Q1 2026 per ELAB's latest filing, from -$548642.0 in the prior quarter.
  • Over five years, Cash from Investing Activities peaked at $33.4 million in Q4 2022 and troughed at -$2.5 million in Q1 2026.
  • A 5-year average of $2.5 million and a median of -$62320.0 in 2024 frame the typical range for Cash from Investing Activities.
  • The widest YoY moves for Cash from Investing Activities: up 415.85% in 2025, down 4296.07% in 2025.
  • Over 5 years, Cash from Investing Activities stood at $33.4 million in 2022, then plunged by 100.03% to -$11191.0 in 2023, then slumped by 3823.55% to -$439084.0 in 2024, then declined by 24.95% to -$548642.0 in 2025, then slumped by 352.68% to -$2.5 million in 2026.
  • According to Business Quant data, Cash from Investing Activities over the past three periods registered -$2.5 million, -$548642.0, and -$2.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn -45.80 Mn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn -92.70 Mn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn -
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 329.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn -49.35 Mn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn -363.46 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn -3.17 Bn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 24.51 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn - -229.72 Mn
10 PMGC Holdings 31.22 Mn 12.43 Mn 385,691.00 -3.68 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -2.48 Mn
Mar 31, 2026 -2.48 Mn
Dec 31, 2025 -548,642.00
Dec 31, 2025 -548,642.00
Sep 30, 2025 -2.20 Mn
Sep 30, 2025 -2.20 Mn
Jun 30, 2025 196,840.00
Jun 30, 2025 196,840.00
Mar 31, 2025 -215,319.00
Mar 31, 2025 -215,319.00
Dec 31, 2024 -439,084.00
Dec 31, 2024 -439,084.00
Sep 30, 2024 -50,000.00
Sep 30, 2024 -50,000.00
Jun 30, 2024 -62,320.00
Jun 30, 2024 -62,320.00
Mar 31, 2024 -59,160.00
Mar 31, 2024 -59,160.00
Mar 31, 2023 -11,191.00
Mar 31, 2023 -11,191.00